世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038803

内分泌薬の世界市場(2024-2028)

TechNavio

Global endocrinology drugs market 2024-2028

発刊日 2024/05/22

言語英語

体裁PDF/177ページ

ライセンス/価格177ページ

0000038803

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

内分泌薬市場は2023年から2028年に368億3,710万米ドル、予測期間中のCAGRは7.45%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。内分泌疾患の罹患率の増加、内分泌学の有望なパイプライン、新規製剤やドラッグデリバリーシステムの調査などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 治療領域別
      ◇ 糖尿病治療薬
      ◇ 成長ホルモン
      ◇ 甲状腺ホルモン障害
      ◇ その他
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、今後数年間の内分泌薬市場成長を牽引する主な要因の1つとして、肥満と内分泌疾患の関連を挙げています。また、内分泌疾患に対するバイオシミラーの使用と老年人口の増加が市場の大きな需要につながります。

内分泌薬市場に関するレポートは、次の分野をカバーしています。

  • 内分泌薬市場の規模
  • 内分泌薬市場の予測
  • 内分泌薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Acerus Pharmaceuticals Corp.
    ➣ Ascendis Pharma AS
    ➣ Bayer AG
    ➣ Beta Cell NV
    ➣ Biocon Ltd.
    ➣ Eli Lilly and Co.
    ➣ Endo International Plc
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Hanmi Pharm Co. Ltd.
    ➣ Ipsen Pharma
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Novo Nordisk AS
    ➣ Oramed Pharmaceuticals Inc.
    ➣ Pfizer Inc.
    ➣ Sanofi SA
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ VeroScience LLC

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Therapy Area
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Endocrinology Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Endocrinology Drugs Market 2018 - 2022 ($ million)
4.2 Therapy Area segment analysis 2018 - 2022
Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy Area
6.1 Market segments
Chart on Therapy Area - Market share 2023-2028 (%)
Data Table on Therapy Area - Market share 2023-2028 (%)
6.2 Comparison by Therapy Area
Chart on Comparison by Therapy Area
Data Table on Comparison by Therapy Area
6.3 Diabetes drugs - Market size and forecast 2023-2028
Chart on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Chart on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Data Table on Diabetes drugs - Year-over-year growth 2023-2028 (%)
6.4 hGH - Market size and forecast 2023-2028
Chart on hGH - Market size and forecast 2023-2028 ($ million)
Data Table on hGH - Market size and forecast 2023-2028 ($ million)
Chart on hGH - Year-over-year growth 2023-2028 (%)
Data Table on hGH - Year-over-year growth 2023-2028 (%)
6.5 Thyroid hormone disorders - Market size and forecast 2023-2028
Chart on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Data Table on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Chart on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Data Table on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Therapy Area
Market opportunity by Therapy Area ($ million)
Data Table on Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals Corp. - Overview
Acerus Pharmaceuticals Corp. - Product / Service
Acerus Pharmaceuticals Corp. - Key offerings
12.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.5 Beta Cell NV
Beta Cell NV - Overview
Beta Cell NV - Product / Service
Beta Cell NV - Key offerings
12.6 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.7 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.10 Hanmi Pharm Co. Ltd.
Hanmi Pharm Co. Ltd. - Overview
Hanmi Pharm Co. Ltd. - Product / Service
Hanmi Pharm Co. Ltd. - Key offerings
12.11 Ipsen Pharma
Ipsen Pharma - Overview
Ipsen Pharma - Business segments
Ipsen Pharma - Key offerings
Ipsen Pharma - Segment focus
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Endocrinology Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Therapy Area - Market share 2023-2028 (%)
Exhibits33: Data Table on Therapy Area - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Therapy Area
Exhibits35: Data Table on Comparison by Therapy Area
Exhibits36: Chart on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on hGH - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on hGH - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on hGH - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on hGH - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Therapy Area ($ million)
Exhibits53: Data Table on Market opportunity by Therapy Area ($ million)
Exhibits54: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits55: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by Distribution Channel
Exhibits57: Data Table on Comparison by Distribution Channel
Exhibits58: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Distribution Channel ($ million)
Exhibits71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape($ million)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: Acerus Pharmaceuticals Corp. - Overview
Exhibits122: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits123: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits124: Bayer AG - Overview
Exhibits125: Bayer AG - Business segments
Exhibits126: Bayer AG - Key news
Exhibits127: Bayer AG - Key offerings
Exhibits128: Bayer AG - Segment focus
Exhibits129: Beta Cell NV - Overview
Exhibits130: Beta Cell NV - Product / Service
Exhibits131: Beta Cell NV - Key offerings
Exhibits132: Eli Lilly and Co. - Overview
Exhibits133: Eli Lilly and Co. - Product / Service
Exhibits134: Eli Lilly and Co. - Key news
Exhibits135: Eli Lilly and Co. - Key offerings
Exhibits136: Endo International Plc - Overview
Exhibits137: Endo International Plc - Business segments
Exhibits138: Endo International Plc - Key news
Exhibits139: Endo International Plc - Key offerings
Exhibits140: Endo International Plc - Segment focus
Exhibits141: F. Hoffmann La Roche Ltd. - Overview
Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits143: F. Hoffmann La Roche Ltd. - Key news
Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits146: GlaxoSmithKline Plc - Overview
Exhibits147: GlaxoSmithKline Plc - Business segments
Exhibits148: GlaxoSmithKline Plc - Key news
Exhibits149: GlaxoSmithKline Plc - Key offerings
Exhibits150: GlaxoSmithKline Plc - Segment focus
Exhibits151: Hanmi Pharm Co. Ltd. - Overview
Exhibits152: Hanmi Pharm Co. Ltd. - Product / Service
Exhibits153: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits154: Ipsen Pharma - Overview
Exhibits155: Ipsen Pharma - Business segments
Exhibits156: Ipsen Pharma - Key offerings
Exhibits157: Ipsen Pharma - Segment focus
Exhibits158: Merck and Co. Inc. - Overview
Exhibits159: Merck and Co. Inc. - Business segments
Exhibits160: Merck and Co. Inc. - Key news
Exhibits161: Merck and Co. Inc. - Key offerings
Exhibits162: Merck and Co. Inc. - Segment focus
Exhibits163: Novartis AG - Overview
Exhibits164: Novartis AG - Business segments
Exhibits165: Novartis AG - Key news
Exhibits166: Novartis AG - Key offerings
Exhibits167: Novartis AG - Segment focus
Exhibits168: Novo Nordisk AS - Overview
Exhibits169: Novo Nordisk AS - Business segments
Exhibits170: Novo Nordisk AS - Key offerings
Exhibits171: Novo Nordisk AS - Segment focus
Exhibits172: Pfizer Inc. - Overview
Exhibits173: Pfizer Inc. - Product / Service
Exhibits174: Pfizer Inc. - Key news
Exhibits175: Pfizer Inc. - Key offerings
Exhibits176: Sanofi SA - Overview
Exhibits177: Sanofi SA - Business segments
Exhibits178: Sanofi SA - Key news
Exhibits179: Sanofi SA - Key offerings
Exhibits180: Sanofi SA - Segment focus
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits183: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits184: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Information sources
Exhibits190: Data validation
Exhibits191: Validation techniques employed for market sizing
Exhibits192: Data synthesis
Exhibits193: 360 degree market analysis
Exhibits194: List of abbreviations

この商品のレポートナンバー

0000038803

TOP